FREDUN PHARMACEUTICALS
Back to Balance Sheet
|
FREDUN PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹18 Cr | ₹19 Cr | ₹21 Cr | ₹45 Cr | ₹32 Cr |
What is the latest Total Non-Current Liabilities ratio of FREDUN PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹19 Cr |
| Mar2023 | ₹21 Cr |
| Mar2022 | ₹45 Cr |
| Mar2021 | ₹32 Cr |
How is Total Non-Current Liabilities of FREDUN PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | -7.10 | |
| Mar2024 | ₹19 Cr | -9.16 | |
| Mar2023 | ₹21 Cr | -52.97 | |
| Mar2022 | ₹45 Cr | 40.78 | |
| Mar2021 | ₹32 Cr | - | |
Compare Total Non-Current Liabilities of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹1,003.0 Cr | 6.5% | 15.6% | 158.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | 6.5% |
15.6% |
158.9% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses